Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate to severe atopic dermatitis after it failed to meet efficacy goals in a… [+833 chars]
Johnson & Johnson halts mid-stage trial of experimental eczema drug - CNBC
Johnson & Johnson said it discontinued a mid-stage study of its experimental drug to treat atopic dermatitis, after it failed to meet efficacy goals.
By:Reuters
Source:CNBC
Published:
Related News
Wiper malware targeted Poland energy grid, but failed to knock out electricity - Ars Technica
Destructive payload unleashed on 10-year anniversary of Russia's attack on Ukraine's grid.
Ars Technica•Dan Goodin
Iconic 51-year-old athletic clothing brand closing permanently - thestreet.com
A well-known sportswear brand that transformed athletic gear is closing and selling its remaining inventory.
TheStreet•Daniel Kline, Celine Provini
Public urged to cut back on electrical usage across central Indiana, southern Indiana - wthr.com
A spokesperson for Hoosier Energy said "high demand for electricity and tight power supplies throughout the Midwest are causing a serious power supply emergency."
WTHR•WTHR.com staff